Blackhawk Capital Partners LLC Acquires 2,610 Shares of Molina Healthcare, Inc $MOH

Blackhawk Capital Partners LLC raised its holdings in Molina Healthcare, Inc (NYSE:MOH) by 95.2% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,351 shares of the company’s stock after purchasing an additional 2,610 shares during the quarter. Blackhawk Capital Partners LLC’s holdings in Molina Healthcare were worth $713,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently made changes to their positions in the company. AQR Capital Management LLC boosted its stake in Molina Healthcare by 217.0% in the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company’s stock valued at $561,475,000 after acquiring an additional 2,008,458 shares during the last quarter. 8 Knots Management LLC purchased a new stake in shares of Molina Healthcare during the 4th quarter worth approximately $198,942,000. Madison Avenue Partners LP purchased a new stake in shares of Molina Healthcare during the 4th quarter worth approximately $110,003,000. Norges Bank bought a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $109,766,000. Finally, Baupost Group LLC MA bought a new stake in shares of Molina Healthcare in the 4th quarter worth approximately $108,463,000. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Stock Down 3.4%

Shares of NYSE MOH opened at $233.44 on Thursday. Molina Healthcare, Inc has a 52 week low of $121.06 and a 52 week high of $244.89. The company has a market cap of $12.16 billion, a P/E ratio of 69.07 and a beta of 0.74. The company has a quick ratio of 1.63, a current ratio of 1.63 and a debt-to-equity ratio of 0.97. The business has a 50-day simple moving average of $201.97 and a two-hundred day simple moving average of $174.74.

Molina Healthcare (NYSE:MOH) last issued its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, beating the consensus estimate of $1.57 by $0.78. The company had revenue of $10.80 billion during the quarter, compared to analysts’ expectations of $10.91 billion. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. Molina Healthcare’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Research analysts anticipate that Molina Healthcare, Inc will post 5.23 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total transaction of $114,930.00. Following the completion of the transaction, the chief accounting officer directly owned 12,815 shares in the company, valued at $2,454,713.25. The trade was a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total value of $3,314,983.32. Following the completion of the transaction, the insider owned 67,175 shares in the company, valued at $12,502,611. This represents a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.44% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Morgan Stanley increased their price objective on Molina Healthcare from $146.00 to $167.00 and gave the company an “equal weight” rating in a report on Thursday, June 4th. Truist Financial upped their price target on Molina Healthcare from $205.00 to $250.00 and gave the company a “hold” rating in a research report on Tuesday. UBS Group increased their price target on Molina Healthcare from $180.00 to $202.00 and gave the stock a “neutral” rating in a research note on Friday, May 22nd. Bank of America raised Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a report on Wednesday, April 29th. Finally, Royal Bank Of Canada boosted their price objective on Molina Healthcare from $216.00 to $248.00 and gave the company a “sector perform” rating in a research note on Thursday, July 9th. Three research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $207.06.

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.